Top Markets
Coin of the day
Simcere Pharmaceutical Group Limited Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited

2096
Rank in Stocks #4368
Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the... Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the comprehensive process of discovering, developing, manufacturing, and commercializing pharmaceutical products. These medicines are distributed to various clients, including distributors, pharmacy chains, and fellow drug manufacturers within China. The company strategically focuses on a diverse range of therapeutic areas, notably oncology, central nervous system conditions, autoimmune diseases, anti-infective treatments, and cardiovascular health, among others. Its extensive product portfolio features key medications such as Sanbexin (an edaravone and dexborneol concentrated solution for injection), Endostar (a recombinant human endostatin injection), ENWEIDA (an envafolimab injection), Softan (rosuvastatin calcium tablets), ZAILIN (amoxicillin in granules, dispersible tablets, or capsules), Iremod (iguratimod tablets), Antine (diclofenac sodium sustained-release capsules or gel), and Orencia (an abatacept injection). Additionally, Simcere offers specialized promotional services for pharmaceutical goods. Demonstrating its commitment to innovation, the group has established a strategic regional licensing collaboration with Vivoryon Therapeutics N.V. This partnership aims to develop and commercialize novel therapies for Alzheimer's disease by targeting the neurotoxic amyloid protein N3pE (pGlu-Aß). Established in 1995, Simcere Pharmaceutical Group Limited is headquartered in Nanjing, China.
Share Price
$1.48
Market Cap
$3.81B
Change (1 day)
0.61%
Change (1 year)
-19.90%
Country
CN
Trade Simcere Pharmaceutical Group Limited (2096)

Category

Stock price history for Simcere Pharmaceutical Group Limited (2096)
Highest end of day price: $1.55 on 2026-08-01

Lowest end of day price: $1.42 on 2020-10-01
Stock price history of Simcere Pharmaceutical Group Limited from 2020 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -6.51%
2025 86.13%
2024 5.24%
2023 -33.80%
2022 10.61%
2021 9.90%
2020 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$549.38 41.89%
US
$1.06K 48.99%
NL
$121.62 -12.98%
AU
$145.86 489.81%
US
$764.47 6.25%
CH